이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Ambu 미래 성장

Future 기준 확인 4/6

Ambu (는) 각각 연간 25.6% 및 11.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 25.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.7% 로 예상됩니다.

주요 정보

25.7%

수익 성장률

26.1%

EPS 성장률

Medical Equipment 수익 성장	18.1%
매출 성장률	11.9%
향후 자기자본 수익률	11.8%
애널리스트 커버리지	Good
마지막 업데이트	01 Jul 2024

최근 미래 성장 업데이트

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

Recent updates

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

수익 및 매출 성장 예측

CPSE:AMBU B - 애널리스트의 미래 추정치 및 과거 재무 데이터 (DKK Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
9/30/2026	6,939	880	650	1,119	5
9/30/2025	6,115	660	494	924	6
9/30/2024	5,387	474	414	773	6
3/31/2024	5,075	367	608	902	N/A
12/31/2023	4,897	238	501	805	N/A
9/30/2023	4,775	168	192	518	N/A
6/30/2023	4,679	-42	-168	217	N/A
3/31/2023	4,612	-65	-318	119	N/A
12/31/2022	4,545	95	-475	25	N/A
9/30/2022	4,444	93	-463	95	N/A
6/30/2022	4,307	222	-401	185	N/A
3/31/2022	4,152	256	-521	107	N/A
12/31/2021	4,031	176	-419	194	N/A
9/30/2021	4,013	247	-256	328	N/A
6/30/2021	3,858	251	-187	347	N/A
3/31/2021	3,832	281	111	593	N/A
12/31/2020	3,820	290	56	511	N/A
9/30/2020	3,567	241	-135	295	N/A
6/30/2020	3,302	146	-24	366	N/A
3/31/2020	3,128	270	-62	277	N/A
12/31/2019	2,924	296	37	330	N/A
9/30/2019	2,820	317	272	533	N/A
6/30/2019	2,943	515	361	597	N/A
3/31/2019	2,843	411	316	553	N/A
12/31/2018	2,709	372	327	560	N/A
9/30/2018	2,606	337	318	554	N/A
6/30/2018	2,506	318	269	498	N/A
3/31/2018	2,434	288	266	456	N/A
12/31/2017	2,396	281	N/A	476	N/A
9/30/2017	2,355	301	N/A	462	N/A
6/30/2017	2,299	306	N/A	403	N/A
3/31/2017	2,215	299	N/A	460	N/A
12/31/2016	2,134	267	N/A	420	N/A
9/30/2016	2,084	250	N/A	369	N/A
6/30/2016	2,047	224	N/A	408	N/A
3/31/2016	2,012	169	N/A	269	N/A
12/31/2015	1,963	175	N/A	246	N/A
9/30/2015	1,889	152	N/A	208	N/A
6/30/2015	1,795	171	N/A	141	N/A
3/31/2015	1,710	184	N/A	137	N/A
12/31/2014	1,630	156	N/A	147	N/A
9/30/2014	1,584	151	N/A	183	N/A
6/30/2014	1,543	94	N/A	167	N/A
3/31/2014	1,524	67	N/A	141	N/A
12/31/2013	1,456	40	N/A	148	N/A
9/30/2013	1,383	48	N/A	122	N/A

애널리스트 미래 성장 예측

수입 대 저축률: AMBU B 의 연간 예상 수익 증가율( 25.6% )이 saving rate( 0.9% 보다 높습니다. ).

수익 vs 시장: AMBU B 의 연간 수익( 25.6% ) Danish 시장( 13% 보다 빠르게 성장할 것으로 예상됩니다. 13% 연간).

고성장 수익: AMBU B 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: AMBU B 의 수익(연간 11.8% ) Danish 시장( 11.2% 보다 빠르게 성장할 것으로 예상됩니다. 11.2% 연간).

고성장 수익: AMBU B 의 수익(연간 11.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: AMBU B 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.7 %).

Ambu 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates increase by 14%

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Recent updates

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Consensus forecasts updated

Second quarter 2022 earnings: Revenues in line with analyst expectations

Price target decreased to kr.137

Less than half of directors are independent

First quarter 2022 earnings: EPS misses analyst expectations

Ambu A/S Revises Revenue Guidance for the Fiscal 2022

Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Upcoming dividend of kr.0.29 per share